Skip to main content
. Author manuscript; available in PMC: 2020 Oct 1.
Published in final edited form as: J Neurovirol. 2019 Jan 22;25(5):722–733. doi: 10.1007/s13365-019-00721-6

Figure 2. HIV-Tat increases beta-oxidation in human primary astrocytes.

Figure 2.

Astrocytes were exposed to 50 ng/ml recombinant HIV-1 Tat for 48h and assessed by immunofluorescence for and GFAP (red) and carnitine palmitoyltransferase 1 (CPT1) (green), a rate limiting enzyme for beta-oxidation. Reprinted with permission from Natarajanseenivasan et al., Cell Death & Disease, 9: 415, 2018, http://creativecommons.org/licenses/by/4.0/.